Regarding "Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs"

被引：2
作者：
Su, I-Hsuan [1 ]
Lund, Jennifer L. [1 ,2 ]
Gaber, Charles E. [3 ]
Sanoff, Hanna K. [2 ,4 ]
Strassle, Paula D. [5 ]
Duchesneau, Emilie D. [1 ,2 ]
机构：
[1] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA
[2] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA
[3] Univ Illinois, Coll Pharm, Dept Pharm Syst Outcomes & Policy, Chicago, IL USA
[4] Univ N Carolina, Dept Med, Div Oncol, Chapel Hill, NC 27515 USA
[5] Natl Inst Minor Hlth & Hlth Dispar, Div Intramural Res, NIH, Bethesda, MD USA
来源：
ONCOLOGIST | 2023年 / 28卷 / 07期
关键词：
BIAS;
D O I：
10.1093/oncolo/oyad130
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E588 / E589
页数：2
相关论文
共 9 条
  • [1] The Timing, the Treatment, the Question: Comparison of Epidemiologic Approaches to Minimize Immortal Time Bias in Real-World Data Using a Surgical Oncology
    Duchesneau, Emilie D.
    Jackson, Bradford E.
    Webster-Clark, Michael
    Lund, Jennifer L.
    Reeder-Hayes, Katherine E.
    Napoles, Anna M.
    Strassle, Paula D.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (11) : 2079 - 2086
  • [2] Examining Bias in Studies of Statin Treatment and Survival in Patients With Cancer
    Emilsson, Louise
    Garcia-Albeniz, Xabier
    Logan, Roger W.
    Caniglia, Ellen C.
    Kalager, Mette
    Hernan, Miguel A.
    [J]. JAMA ONCOLOGY, 2018, 4 (01) : 63 - 70
  • [3] Trimodality Therapy vs Definitive Chemoradiation in Older Adults With Locally Advanced Esophageal Cancer
    Gaber, Charles E.
    Shaheen, Nicholas J.
    Edwards, Jessie K.
    Sandler, Robert S.
    Nichols, Hazel B.
    Sanoff, Hanna K.
    Lund, Jennifer L.
    [J]. JNCI CANCER SPECTRUM, 2022, 6 (06)
  • [4] Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs
    Hao, Zhonglin
    Parasramka, Saurabh
    Chen, Quan
    Jacob, Aasems
    Huang, Bin
    Mullett, Timothy
    Benson, Al B.
    [J]. ONCOLOGIST, 2023, 28 (01) : 48 - 58
  • [5] Target Trial Emulation A Framework for Causal Inference From Observational Data
    Hernan, Miguel A.
    Wang, Wei
    Leaf, David E.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (24): : 2446 - 2447
  • [6] Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses
    Hernan, Miguel A.
    Sauer, Brian C.
    Hernandez-Diaz, Sonia
    Platt, Robert
    Shrier, Ian
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2016, 79 : 70 - 75
  • [7] Reflection on modern methods: trial emulation in the presence of immortal-time bias. Assessing the benefit of major surgery for elderly lung cancer patients using observational data
    Maringe, Camille
    Majano, Sara Benitez
    Exarchakou, Aimilia
    Smith, Matthew
    Rachet, Bernard
    Belot, Aurelien
    Leyrat, Clemence
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2020, 49 (05) : 1719 - 1729
  • [8] Oke J, 2021, LEAD TIME BIAS
  • [9] Immortal time bias in observational studies of drug effects
    Suissa, Samy
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (03) : 241 - 249
1